Josep Tabernero

Also affiliated with Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, CIBBIM-Nanomedicine, Vall d'Hebron Institute of Oncology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer”.

Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer

New England Journal of Medicine(2025)10.1056/nejmoa2501912

N/A

1.9DataRank · unranked

114 citations

Takayuki Yoshino, Lin Shen, Sara Lonardi, Eric Van Cutsem, Cathy Eng +15 more

Pembrolizumab in HER2-Positive Gastric Cancer

New England Journal of Medicine(2024)10.1056/nejmc2408121

N/A

1.4DataRank · unranked

65 citations

Akihito Kawazoe, Yuxian Bai, Jianming Xu, Sara Lonardi, Jean Phillipe Metges +21 more

Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-024-03443-3

N/A

1.3DataRank · unranked

108 citations

Takayuki Yoshino, Eric Van Cutsem, Cathy Eng, Tae Won Kim, Harpreet Wasan +10 more

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

New England Journal of Medicine(2013)10.1056/nejmoa1304369

N/A

1.3DataRank · unranked

6585 citations

Thomas Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey Infante, Fruzsina Molnar-Gabor +26 more

The landscape of somatic copy-number alteration across human cancers

Nature(2010)10.1038/nature08822

N/A

1.2DataRank · unranked

4101 citations

Craig H. Mermel, Dale A. Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan +61 more

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAFV600E-MutantKRASWild-Type Metastatic Colorectal Cancer

The Oncologist(2023)10.1093/oncolo/oyad007

N/A

1.2DataRank · unranked

53 citations

Eric Van Cutsem, Elena Garralda, David Tai, Filippo de Braud, Ravit Geva +9 more

A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors

Clinical Cancer Research(2015)10.1158/1078-0432.ccr-14-1814

N/A

0.868DataRank · unranked

326 citations

Josep Tabernero, Filip Janku, Zev A. Wainberg, Luis Paz-Ares, Johan Vansteenkiste +13 more

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

Nature Genetics(2011)10.1038/ng.936

N/A

0.838DataRank · unranked

266 citations

Michael S. Lawrence, Lear E. Brace, Alex H. Ramos, Timothy R. Dreszer, Kristian Cibulskis +37 more

SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR BRAF V600E-mutant mCRC

Future Oncology(2024)10.2217/fon-2022-1249

N/A

0.561DataRank · unranked

41 citations

Scott Kopetz, Josep Tabernero, Tanios Bekaii-Saab, Julien Taieb, Takayuki Yoshino +6 more

Two decades of advances in clinical oncology — lessons learned and future directions

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00945-4

N/A

0.477DataRank · unranked

23 citations

Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry +14 more

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer

The Oncologist(2023)10.1093/oncolo/oyad210

N/A

0.250DataRank · unranked

3 citations

Rona Yaeger, Jean‐Pierre Delord, Josep Tabernero, Lillian L. Siu, Michel Ducreux +9 more

Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal Cancer

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0002

N/A

0DataRank · unranked

3 citations

Jean-François Martini, Lincoln W. Pasquina, Brian Tunquist, Xiaosong Zhang, Fatima Khaiser +10 more

SARS-CoV-2 vaccination and phase 1 cancer clinical trials

The Lancet Oncology(2021)10.1016/s1470-2045(21)00017-6

N/A

0DataRank · unranked

12 citations

Lillian L. Siu, Emiliano Calvo, Martijn P. Lolkema, Patricia LoRusso, Jean‐Charles Soria +5 more

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial

ESMO Open(2025)10.1016/j.esmoop.2025.105892

N/A

0DataRank · unranked

0 citations

Salvatore Siena, A. Sartore-Bianchi, Javier Ros, F. Ciardello, E. Martinelli +38 more

A path to translation: How 3D patient tumor avatars enable next generation precision oncology

Cancer Cell(2022)10.1016/j.ccell.2022.09.017

N/A

0DataRank · unranked

66 citations

Margarida Barroso, Milan G. Chheda, Hans Clevers, Élena Elez, Salma Kaochar +21 more

A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of Glioblastoma

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0201

N/A

0DataRank · unranked

33 citations

Inja Waldhauer, Ester Planas‐Rigol, Ester Bonfill‐Teixidor, Alexandra Arias, Valeria Nicolini +30 more